# Spyre Therapeutics, Inc.: Form DEF 14A, filed Apr 14, 2025

- Company: [Spyre Therapeutics, Inc.](/companies/syre.md) (CIK 1636282)
- Form: DEF 14A
- Filed: 2025-04-14
- Accepted by EDGAR: Apr 14, 2025, 20:33 ET
- Period: 2025-05-29
- Accession: 0001636282-25-000038
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1636282/000163628225000038/syre-20250414.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1636282/000163628225000038/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1636282/000163628225000038/syre-20250414.htm

Filed Apr 14, 2025.
Source: SEC EDGAR, the filing index for accession 0001636282-25-000038. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.